» Articles » PMID: 10698507

Tandem-duplicated Flt3 Constitutively Activates STAT5 and MAP Kinase and Introduces Autonomous Cell Growth in IL-3-dependent Cell Lines

Overview
Journal Oncogene
Date 2000 Mar 4
PMID 10698507
Citations 178
Authors
Affiliations
Soon will be listed here.
Abstract

We have recently identified an internal tandem duplication of the human Flt3 gene in approximately 20% of acute myeloid leukemia (AML) cases. In the present study, the wild-type and the mutant Flt3 genes were transfected into two IL-3-dependent cell lines, 32D and BA/F3 cells. Mutant Flt3-transfected cells exhibited autonomous growth while wild-type Flt3-transfected cells with the continuous stimulation of Flt3 ligand exhibited a minimal proliferation. Cells expressing mutant Flt3 showed constitutive activation of STAT5 and MAP kinase. In contrast, Flt3 ligand stimulation caused rapid activation of MAP kinase but not STAT5 in cells expressing wild-type Flt3. Finally, we found constitutive activation of MAP kinase and STAT5 in all clinical samples of AML patients with mutant Flt3. Our study shows the significance of internal tandem duplication of Flt3 receptors for leukemia cell expansion.

Citing Articles

Homoharringtonine: mechanisms, clinical applications and research progress.

Wang W, He L, Lin T, Xiang F, Wu Y, Zhou F Front Oncol. 2025; 15:1522273.

PMID: 39949739 PMC: 11821653. DOI: 10.3389/fonc.2025.1522273.


Oncogenic FLT3 internal tandem duplications (ITD) and CD45/PTPRC control osteoclast functions and bone microarchitecture.

Lossius-Cott C, Annoh A, Bens M, Nietzsche S, Hoffmann B, Figge M JBMR Plus. 2025; 9(3):ziae173.

PMID: 39906260 PMC: 11788565. DOI: 10.1093/jbmrpl/ziae173.


Modelling post-chemotherapy stem cell dynamics in the bone marrow niche of AML patients.

Zhu C, Stiehl T Sci Rep. 2024; 14(1):25060.

PMID: 39443599 PMC: 11500015. DOI: 10.1038/s41598-024-75429-7.


Radiotherapy Combined with Intralesional Immunostimulatory Agents for Soft Tissue Sarcomas.

Su C, Kim S, Wang C, Kirsch D, Monjazeb A Semin Radiat Oncol. 2024; 34(2):243-257.

PMID: 38508788 PMC: 11216412. DOI: 10.1016/j.semradonc.2024.01.001.


FLT3 tyrosine kinase inhibition modulates PRC2 and promotes differentiation in acute myeloid leukemia.

Sung P, Selvam M, Riedel S, Xie H, Bryant K, Manning B Leukemia. 2024; 38(2):291-301.

PMID: 38182819 PMC: 11141246. DOI: 10.1038/s41375-023-02131-4.